Results 31 to 40 of about 3,005,108 (342)
How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
Cancers, 2020 Adenohypophyseal tumors, which were recently renamed pituitary neuroendocrine tumors (PitNET), are mostly benign, but may present various behaviors: invasive, “aggressive” and malignant with metastases.
J. Trouillas +5 more
semanticscholar +1 more source
MEN1 promotes ferroptosis by inhibiting mTOR-SCD1 axis in pancreatic neuroendocrine tumors
Acta Biochimica et Biophysica Sinica, 2022 Pancreatic neuroendocrine tumor (pNET) is the second most common malignant tumors of the pancreas. Multiple endocrine neoplasia 1 ( MEN1) is the most frequently mutated gene in pNETs and MEN1-encoded protein, menin, is a scaffold ...
Ye Zeng +16 more
doaj +1 more source
Discussing motherhood when the oncological prognosis is dire: ethical considerations for physicians
ESMO Open, 2020 Physicians are increasingly open to discussing and supporting pregnancy after cancer treatment. However, counselling patients who are seeking pregnancy despite advanced oncological disease and/or uncertain prognosis is still challenging. Two paradigmatic
Francesca Spada +3 more
doaj +1 more source
Clinical Cancer Research, 2020 Purpose: Immune checkpoint blockade has improved outcomes across tumor types; little is known about the efficacy of these agents in rare tumors. We report the results of the (nonpancreatic) neuroendocrine neoplasm cohort of SWOG S1609 dual anti–CTLA-4 ...
S. Patel +21 more
semanticscholar +1 more source
Biomarkers in neuroendocrine tumors
Frontiers in Bioscience, 2010 Here, we review the role of clinical biomarkers (tissue and circulating markers) in the management of neuroendocrine tumors. These tumors may originate in different organs, from cells embriologically different but expressing common phenotypic characteristics, such as the immuno-reactivity for markers of neuro endocrine differentiation (defined as "pan ...
BERRETTA M +7 more
openaire +6 more sources
THE GASTROINTESTINAL NEUROENDOCRIN TUMORS
Arta Medica, 2021 Objectives. The gastrointestinal neuroendocrin tumors are rare events with clinical presentation widely variable and surgical management that is often challenging. Material and methods. We performed a retrospective study in the First Surgical Clinic, St Spiridon University Hospital, “Grigore T.
Delia Ciobanu +8 more
openaire +4 more sources
Frontiers in Endocrinology, 2018 Background: Available neuroendocrine biomarkers are considered to have insufficient accuracy to discriminate patients with gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) from healthy controls.
Mark J. C. van Treijen +15 more
doaj +1 more source
Frontiers in Surgery, 2022 BackgroundPancreatic neuroendocrine tumors (pNETs) and solid pseudopapillary tumors (SPTs) are two of the most common pancreatic neoplasms with different treatment procedures.
Hai-Feng Hu +37 more
doaj +1 more source
Endocrine Connections, 2019 Introduction: Current monoanalyte biomarkers are ineffective in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). NETest, a novel multianalyte signature, provides molecular information relevant to disease biology.
Anna Malczewska +9 more
doaj +1 more source
Medicine, 2019 Objective: To evaluate the prognostic value of pancreatic neuroendocrine tumors (pNETs) with different metastatic patterns. Methods: Data of pNETs cases were extracted from the Surveillance, Epidemiology, and End Result (SEER) database.
Sumei Wang +3 more
semanticscholar +1 more source